Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Nuclear Condensate Assembly by Drosophila Keap1 in Oxidative

    2026-04-12

    Nuclear Condensate Assembly by Drosophila Keap1 in Oxidative Stress

    Study Background and Research Question

    The Keap1-Nrf2 signaling axis is a well-established regulator of cellular defense, orchestrating transcriptional responses to oxidative and xenobiotic stresses. In the canonical pathway, Keap1 targets Nrf2 for proteasomal degradation in the cytoplasm under homeostatic conditions. Oxidative cues disrupt this interaction, permitting Nrf2 nuclear accumulation and subsequent activation of antioxidant gene programs. Beyond cytoplasmic regulation, mounting evidence points to nuclear roles for Keap1 family proteins, yet the mechanisms underpinning these functions remain poorly characterized. The reference study by Ji et al. (Antioxidants 2026, 15, 134) directly addresses this knowledge gap by investigating how the Drosophila Keap1 ortholog (dKeap1) responds to oxidative stress at the nuclear level and its implications for transcriptional regulation and development.

    Key Innovation from the Reference Study

    The core innovation of this research lies in the discovery that dKeap1 assembles into stable nuclear condensates upon oxidative stress. Through a combination of live-cell imaging, domain dissection, and in vitro phase separation assays, the authors demonstrate that both the N-terminal and C-terminal domains of dKeap1 are essential for nuclear foci formation. Notably, two intrinsically disordered regions (IDRs) within the C-terminal domain are identified as key drivers of condensate assembly. These observations position dKeap1 as a nuclear scaffold capable of forming biomolecular condensates, potentially linking nuclear Keap1 activity to chromatin engagement and transcriptional control (reference paper).

    Methods and Experimental Design Insights

    The study employed a multi-pronged strategy to dissect dKeap1's nuclear behavior:

    • Genetic Models: Drosophila stocks were engineered to express fluorescently tagged dKeap1 variants.
    • Live Imaging: Fluorescence microscopy tracked dKeap1 localization dynamics in real time following oxidative treatment.
    • Fluorescence Recovery After Photobleaching (FRAP): Quantified the mobility and stability of dKeap1 within nuclear condensates.
    • Domain Mutation and Deletion: Systematic truncations and deletions of NTD, CTD, and Kelch domains revealed their necessity for phase separation and subcellular targeting.
    • In Vitro Assays: Purified CTD-YFP fusion proteins were tested for condensate formation outside the cellular context, confirming that phase separation is an intrinsic property of dKeap1's C-terminal region.
    This integrated approach allowed the authors to map structural determinants of condensate formation and connect these features to functional outputs.


    Core Findings and Why They Matter

    Key observations from the study include:

    • Oxidative Stress-Induced Condensates: dKeap1 accumulates in the nucleus and forms stable foci in response to oxidative stress. FRAP assays revealed that these nuclear condensates have reduced molecular mobility, indicative of phase-separated compartments (reference paper).
    • Domain Requirements: Both NTD and CTD are essential for nuclear condensate assembly. Intrinsically disordered regions (IDRs) within the CTD drive phase separation, as demonstrated by in vitro condensate formation of CTD-YFP constructs.
    • Kelch Domain Suppression: Deletion of the Kelch domain led to constitutive cytoplasmic foci formation, suggesting an inhibitory role for this domain in condensate assembly under basal conditions.
    • Transcriptional and Chromatin Engagement: The findings support a model in which dKeap1 nuclear condensates facilitate chromatin binding and transcriptional regulation, extending the canonical role of Keap1 beyond cytoplasmic Nrf2 degradation.
    These results illuminate a novel phase separation mechanism for stress-induced nuclear Keap1 function. They also provide a mechanistic basis for linking nuclear dKeap1 activity to developmental gene regulation and chromatin organization.


    Comparison with Existing Internal Articles

    Recent internal literature has explored the intersection of nuclear protein condensates and advanced protein purification methods. For example, "PreScission Protease (PSP): Mechanistic Precision Driving Translational Research" contextualizes how discoveries in biomolecular condensate biology inform next-generation purification workflows, including the use of HRV 3C protease-based tools. Similarly, the article "Unleashing Precision in Protein Purification" connects the mechanistic specificity of PreScission Protease—particularly its cleavage at the Gln-Gly bond—to the isolation of phase-separating proteins for biophysical analysis.

    While these articles focus on the practical utility of recombinant fusion proteases for isolating proteins that form condensates, the reference paper by Ji et al. provides direct biological evidence for why such workflows are necessary: phase-separating proteins like dKeap1 require precise, tag-free purification to preserve their native assembly properties during in vitro reconstitution and downstream study.

    Limitations and Transferability

    The study by Ji et al. is centered on Drosophila models and in vitro systems, which may not fully recapitulate mammalian Keap1-Nrf2 dynamics or disease-relevant processes. The exact composition and regulatory partners of the nuclear dKeap1 condensates remain to be defined, and the functional consequences for gene expression and development require further exploration using chromatin immunoprecipitation and in vivo models. Additionally, while in vitro phase separation of dKeap1 CTD supports an intrinsic biophysical property, the physiological regulation of condensate assembly in diverse cell types is not yet fully understood (reference paper).

    Protocol Parameters

    • assay: In vitro condensate reconstitution | value_with_unit: 1–10 μM protein concentration | applicability: phase separation of CTD-YFP fusions | rationale: Sufficient for spontaneous assembly of condensates in test tube | source_type: paper | source_link: https://doi.org/10.3390/antiox15010134
    • assay: Oxidative stress induction | value_with_unit: 0.5–2 mM H2O2 (30–60 min) | applicability: triggers nuclear condensate formation | rationale: Mimics physiologic oxidative bursts in Drosophila cells | source_type: paper | source_link: https://doi.org/10.3390/antiox15010134
    • assay: Protease cleavage of GST-fusions | value_with_unit: 1–10 units/mg fusion protein, 4°C, 2–16 h | applicability: recovery of tag-free dKeap1 for in vitro assays | rationale: Maintains protein stability and activity during cleavage | source_type: workflow_recommendation
    • assay: Fluorescence recovery after photobleaching (FRAP) | value_with_unit: 5–60 s recovery window | applicability: measures molecular mobility within condensates | rationale: Quantifies stability of phase-separated assemblies | source_type: paper | source_link: https://doi.org/10.3390/antiox15010134

    Research Support Resources

    To facilitate studies of nuclear condensate biology and recombinant protein behavior, researchers may consider using PreScission Protease (PSP) (SKU K1101) for precise GST fusion protein cleavage at low temperatures. This HRV 3C protease enables efficient, sequence-specific removal of affinity tags—a workflow recommended for preserving the native properties of phase-separating proteins such as dKeap1 ([product_spec](https://www.apexbt.com/prescission-protease-psp.html)). For further methodological insights and benchmarking, see this internal article detailing PSP's specificity and optimal use.